A Phase 2 Study of Carfilzomib and Bone Metabolism in Patients With Multiple Myeloma in First Relapse or Refractory to First Line Therapy
Phase of Trial: Phase II
Latest Information Update: 04 Nov 2016
At a glance
- Drugs Carfilzomib (Primary) ; Dexamethasone; Dexamethasone
- Indications Multiple myeloma
- Focus Biomarker; Therapeutic Use
- 29 Jul 2016 Status changed from active, no longer recruiting to discontinued.
- 12 May 2016 Planned End Date changed from 1 Sep 2015 to 1 Oct 2016.
- 12 May 2016 Planned primary completion date changed from 1 Sep 2016 to 1 Oct 2016.